Email this article DYNAMICS OF CYTOKINE PRODUCTION INADULTS AFTER ADMINISTRATION OF INFLUENZAVACCINE FROM А/CALIFORNIA/7/2009(H1N1) STRAIN
- Authors: Terkacheva OA1, Kostinov MP1, Zhirova SN1, Cherdantsev AP1, Terkacheva OA2, Kostinov MP2, Zhirova SN2, Cherdantsev AP2
-
Affiliations:
- Mechnikov Research Institute of Vaccines andSera, Moscow, Russia
- Issue: Vol 89, No 1 (2012)
- Pages: 30-35
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.03.2012
- URL: https://microbiol.crie.ru/jour/article/view/13650
- ID: 13650
Cite item
Full Text
Abstract
cytokines in healthy adults after administration
of inactivated subunit monovalent influenza
vaccine, А/California/7/2009 (H1N1) strain.
Materials and methods. Levels of IFN, IFN,
TNF cytokines were studied in blood sera of
58 mostly healthy adults aged 18 - 60 years.
Kits for enzyme immunoassay determination of
cytokine levels (Vector-Best, Novosibirsk) were
used in the study. Antibody titers to А/California/7/2009 (H1N1) strain were determined
at analogous time by using microneutralization
reaction (MNR). Results. Changes in the level
of IFN, IFN, TNF in healthy volunteers
immunized by pandemic influenza vaccine were
evaluated. Vaccine was safe. Two immunizations
did not result in an increase of TNF level that
is an additional evidence of vaccine safety. IFN
level had a tendency to increase in vaccinated
volunteers. IFN levels in volunteers with normal
level of this cytokine (below 10 pg/ml) were
increased significantly after the second immunization
(from 2.66±2.48 to 5.21±2.56).
Correlation analysis showed that there is a strong
negative association between IFN, IFN and
seroconversion.
Keywords
About the authors
O A Terkacheva
M P Kostinov
S N Zhirova
A P Cherdantsev
O A Terkacheva
Mechnikov Research Institute of Vaccines andSera, Moscow, RussiaMechnikov Research Institute of Vaccines andSera, Moscow, Russia
M P Kostinov
Mechnikov Research Institute of Vaccines andSera, Moscow, RussiaMechnikov Research Institute of Vaccines andSera, Moscow, Russia
S N Zhirova
Mechnikov Research Institute of Vaccines andSera, Moscow, RussiaMechnikov Research Institute of Vaccines andSera, Moscow, Russia
A P Cherdantsev
Mechnikov Research Institute of Vaccines andSera, Moscow, RussiaMechnikov Research Institute of Vaccines andSera, Moscow, Russia
References
- Богомолов С.В., Жирова С.Н., Костинов М.П. Цитокиновый профиль и содержание антител у взрослых после введения сплит-вакцины против гриппа. Журн. микробиол. 2008, 5: 57-61.
- Боровиков В. Statistica, искусство анализа данных на компьютере. Спб, Питер, 2001.
- Ермолаев О.Ю. Математическая статистика для психологов, 2003.
- Медуницин Н.В. Вакцинология. М., Триада-Х, 2010.
- Шмелев В.А. Интерферон-гамма, фактор некроза опухолей, тимозин-альфа1 противоинфекционные и противоопухолевые цитокины и препараты. Медпрактика-М, 2008
- Basta N.E., Chao D.L., Halloran M.E. et al. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am. J. Epidemiol. 2009, 6: 679-686.
- Centers for Disease Control and Prevention (CDC). Update on Influenza A (H1N1) 2009 Monovalent vaccines. Posted: 11.16.2009. Morb. Mortal. Wkly Rep. 2009, 39: 1100-1101.
- Centers for Disease Control and Prevention (CDC). Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, 2009. Morb. Mortal. Wkly. Rep.2009, 48: 1351-1356.
- Food and Drug Administration Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS). United States, 1991-2009.
- Liang X.F., Wang H.Q., Wang J.Z. et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2010, 375: 56-66.
- Nicoll A., Ammon A., Amato A. et al. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health. 2010, 1: 14-23.
Supplementary files
